Eleuterio Ferrannini

52PUBLICATIONS
110CO-AUTHORS
Food properties (incl. characteristics and health benefits)Molecular targetsSport and exercise psychologyNutrigenomics and personalised nutritionNutritional epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (52)

|Mar 12, 2026
Impact of canagliflozin on the cardiorenal effects of dietary sodium intake in type 2 diabetes: a post hoc analysis of the CREDENCE trial.

Martina Chiriacò, Domenico Tricò, Alberto Giannoni

|Mar 12, 2026
Beta cell glucose sensitivity identifies clinical response to disease-modifying therapies initiated at stage 3 type 1 diabetes onset.

Carmella Evans-Molina, Stephen E Gitelman, Andrea Mari

|Sep 02, 2025
Effects of Dorzagliatin, a Glucokinase Activator, on α- and β-Cell Function in Individuals With Impaired and Normal Glucose Tolerance.

Zhengli Bai, Ke Wang, Tiffany Yau

|Dec 04, 2024
Association between glycosuria and albuminuria in patients with type 2 diabetes from the CREDENCE trial: a mechanistic link?

Ele Ferrannini, Anna Solini, Andrea Natali

|Jul 08, 2024
GLP-1 Receptor Agonist Treatment Improves Fasting and Postprandial Lipidomic Profiles Independently of Diabetes and Weight Loss.

Giuseppe Della Pepa, Bárbara G Patrício, Fabrizia Carli

|Jun 28, 2024
SGLT2 Inhibitor Dapagliflozin Increases Skeletal Muscle and Brain Fatty Acid Uptake in Individuals With Type 2 Diabetes: A Randomized Double-Blind Placebo-Controlled Positron Emission Tomography Study.

Aino Latva-Rasku, Eleni Rebelos, Jouni Tuisku

Pageof 9

Frequent Collaborators

8 joint publications

Andrea Mari

7 joint publications

Eleni Rebelos

6 joint publications

Pirjo Nuutila

4 joint publications

Julio Rosenstock